PB2296: ROBUST BRUTON’S TYROSINE KINASE (BTK) DEGRADATION WITH NX-5948, AN ORAL BTK DEGRADER, IN A FIRST-IN-HUMAN PHASE 1A TRIAL IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

Detalhes bibliográficos
Principais autores:	Kim Linton, Francesco Forconi, David Lewis, John Riches, Dima El-Sharkawi, Mary Gleeson, Sarah G Injac, Srinand Nandakumar, May Tan, Ganesh Cherala, Graham P Collins
Formato:	Artigo
Idioma:	English
Publicado em:	Wiley 2023-08-01
coleção:	HemaSphere
Acesso em linha:	http://journals.lww.com/10.1097/01.HS9.0000975912.59317.8d

Internet